Reaction
Graft Dysfunction reporting signals
As of the last recalculation, Graft Dysfunction appears in 286 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is ANTI-THYMOCYTE GLOBULIN (RABBIT) (PRR 204.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Anti-Thymocyte Globulin (Rabbit) | 21 | 204.4 | 204.9 |
| Basiliximab | 23 | 154.7 | 155.0 |
| Mycophenolate Mofetil | 114 | 100.9 | 101.0 |
| Mycophenolate Mofetil Hydrochloride | 114 | 100.7 | 100.8 |
| Cyclosporine | 99 | 98.5 | 98.6 |
| Zidovudine | 14 | 80.1 | 80.1 |
| Abacavir Sulfate | 10 | 77.4 | 77.5 |
| Ganciclovir Sodium | 8 | 56.6 | 56.6 |
| Sirolimus | 10 | 55.9 | 56.0 |
| Raltegravir | 9 | 40.9 | 40.9 |
| Efavirenz | 6 | 40.0 | 40.0 |